Full Text
The Use of Patient Reported Outcomes (Pros) By the Pharmaceutical Industry in Japan – A Brief Review of Pmda Data in Comparison With Fda and Ema-Approved Label Claims

Abstract

Authors

D.A. Ledesma E. Tanaka K. Adachi B. Rossi

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×